Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances
Allergies · 02.04.2026 · 6 (2) · 11
DOI: 10.3390/allergies6020011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergies, online erschienen am 02.04.2026. Verfasst von Maykon Jhuly Martins de Paiva und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic urticaria (CU) is a mast cell-driven inflammatory skin disorder characterized by recurrent wheals, angioedema, or both lasting more than six weeks, often resulting in significant impairment of quality of life. Although CU has traditionally been regarded as a predominantly histamine-mediated condition, evidence accumulated over the past decade has redefined chronic spontaneous urticaria (CSU) as a complex immune-mediated disease with marked biological heterogeneity. Distinct pathogenic mechanisms involving autoimmune pathways, dysregulated mast cell activation, and chronic inflammatory networks have been identified, providing a mechanistic basis for disease persistence, variable severity, and therapeutic refractoriness. This review synthesizes current concepts in CSU pathophysiology, with emphasis on mast cell biology, autoimmune endotypes, and inflammatory amplification mechanisms. We further discuss emerging biomarkers with potential relevance for disease stratification and treatment prediction, as well as established and novel therapeutic strategies targeting key pathogenic pathways. By integrating mechanistic insights with clinical implications, this review highlights the transition toward endotype-driven and biomarker-guided management of chronic urticaria.
Zitieren
APA
Paiva, M. J. M. D., Araújo, L. C. D., Marinho, M. D. O., Paiva, R. F. D. D., Costa, V. P. D. S., Faria, G. P. S. D., Souza, G. S. D., Herrera, S. D. S. C., Damasceno, I. A. D. M., Santos, T. T. D., Panontin, J. F., & D’Alessandro, W. B. (2026). Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances. Allergies, 6(2), 11. https://doi.org/10.3390/allergies6020011
Vancouver
Paiva MJMD, Araújo LCD, Marinho MDO, Paiva RFDD, Costa VPDS, Faria GPSD, et al. Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances. Allergies. 2026;6(2):11. doi:10.3390/allergies6020011
BibTeX
@article{Paiva2026,
author = {Paiva, Maykon Jhuly Martins de and Araújo, Livia Cavalcante de and Marinho, Maressa de Oliveira and Paiva, Renata Ferreira Diogo de and Costa, Vitória Pires dos Santos and Faria, Gabriela Pires Santomé de and Souza, Guilherme Silva de and Herrera, Sávia Denise Silva Carlotto and Damasceno, Iangla Araújo de Melo and Santos, Taides Tavares dos and Panontin, Juliane Farinelli and D’Alessandro, Walmirton Bezerra},
title = {Chronic Spontaneous Urticaria: Pathophysiological Mechanisms, Emerging Biomarkers, and Therapeutic Advances},
journal = {Allergies},
year = {2026},
volume = {6},
number = {2},
pages = {11},
doi = {10.3390/allergies6020011}
}
EUVIMED